MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.

Hearing loss is one of the most common sequelae in survivors of pneumococcal meningitis, affecting up to 26% of them. Here, we established the first mouse model of meningitis-associated hearing loss and investigated the role played by the Toll-like receptor-associated adapter molecule MyD88. C57BL/6 mice were infected intracisternally by Streptococcus pneumoniae. By use of audiometry and histological analysis, cochleae were assessed in uninfected control mice during the acute stage and after recovery. MyD88-deficient mice were analyzed 24 h after infection. Wild-type mice lost hearing capacity to a significant degree, which was accompanied by a granulocytic cochlear inflammation. After recovery, hearing loss was still evident, and spiral ganglion neuronal loss, hair cell damage, and fibrocytic occlusion of the cochlea were observed. In contrast, mice lacking MyD88 developed significantly less hearing loss and had diminished cochlear inflammation. Our results strongly suggest a proinflammatory role for MyD88 in the initiation of the inflammatory response during pneumococcal meningitis-associated labyrinthitis.

[1]  R. Coimbra,et al.  Doxycycline Reduces Mortality and Injury to the Brain and Cochlea in Experimental Pneumococcal Meningitis , 2006, Infection and Immunity.

[2]  H. Brodie,et al.  Inhibition of Post-Meningitic Cochlear Injury with Cerebrospinal Fluid Irrigation , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[3]  H. Brodie,et al.  The Effects of Superoxide Dismutase in Gerbils with Bacterial Meningitis , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[4]  H. Wagner,et al.  MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. , 2004, Brain : a journal of neurology.

[5]  H. Pfister,et al.  Meningitis‐associated hearing loss: Protection by adjunctive antioxidant therapy , 2003, Annals of neurology.

[6]  U. Göbel,et al.  Lipoteichoic Acid (LTA) of Streptococcus pneumoniaeand Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved* , 2003, The Journal of Biological Chemistry.

[7]  H. Pfister,et al.  Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. , 2003, Brain : a journal of neurology.

[8]  H. Pfister,et al.  Morphological Correlates of Acute and Permanent Hearing Loss During Experimental Pneumococcal Meningitis , 2003, Brain pathology.

[9]  M. Lipsitch,et al.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Wagner,et al.  Toll-Like Receptor 2 Participates in Mediation of Immune Response in Experimental Pneumococcal Meningitis1 , 2003, The Journal of Immunology.

[11]  R. Flavell,et al.  Role of Caspase‐1 in experimental pneumococcal meningitis: Evidence from pharmacologic Caspase inhibition and Caspase‐1‐deficient mice , 2002, Annals of neurology.

[12]  J. Nadol,et al.  Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac. , 1999, The Journal of infectious diseases.

[13]  J. Stephen,et al.  Ultrastructural damage to the organ of corti during acute experimental Escherichia coli and pneumococcal meningitis in guinea pigs. , 1996, Acta oto-laryngologica.

[14]  S. Merchant,et al.  A human temporal bone study of acute bacterial meningogenic labyrinthitis. , 1996, The American journal of otology.

[15]  R. Levine,et al.  Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. , 1993, The Journal of infectious diseases.